MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival

Kirti Bhatt, Li Zhou, Qing Sheng Mi, Shuang Huang, Jin-Xiong She, Zheng Dong

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

MicroRNAs are small noncoding RNAs that are produced endogenously and have emerged as important regulators in pathophysiological conditions such as development and tumorigenesis. Very little is known about the regulation of microRNAs in renal diseases, including acute kidney injury (AKI). In this study, we examined the regulation of microRNA-34a (miR-34a) in experimental models of cisplatin-induced AKI and nephrotoxicity. By Northern blot and real-time polymerase chain reaction analyses, we detected an induction of miR-34a in vitro during cisplatin treatment of mouse proximal tubular cells and also in vivo during cisplatin nephrotoxicity in C57BL/6 mice. In cultured cells, miR-34a was induced within a few hours. In mice, miR-34a induction was detectable in renal tissues after 1 d of cisplatin treatment and increased to approximately four-fold of control at d 3. During cisplatin treatment, p53 was activated. Inhibition of p53 with pifithrin-α abrogated the induction of miR-34a during cisplatin treatment of proximal tubular cells. In vivo, miR-34a induction by cisplatin was abrogated in p53-deficient mice, a result that further confirms a role for p53 in miR-34a induction during cisplatin nephrotoxicity. Functionally, antagonism of miR-34a with specific antisense oligonucleotides increased cell death during cisplatin treatment. Collectively, the results suggest that miR-34a is induced via p53 during cisplatin nephrotoxicity and may play a cytoprotective role for cell survival.

Original languageEnglish (US)
Pages (from-to)409-416
Number of pages8
JournalMolecular Medicine
Volume16
Issue number9-10
DOIs
StatePublished - Sep 1 2010

Fingerprint

MicroRNAs
Cisplatin
Cell Survival
Acute Kidney Injury
Kidney
Small Untranslated RNA
Antisense Oligonucleotides
Inbred C57BL Mouse
Northern Blotting
Real-Time Polymerase Chain Reaction
Cultured Cells
Carcinogenesis
Cell Death
Theoretical Models

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology
  • Molecular Medicine
  • Genetics(clinical)

Cite this

MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival. / Bhatt, Kirti; Zhou, Li; Mi, Qing Sheng; Huang, Shuang; She, Jin-Xiong; Dong, Zheng.

In: Molecular Medicine, Vol. 16, No. 9-10, 01.09.2010, p. 409-416.

Research output: Contribution to journalArticle

Bhatt, Kirti ; Zhou, Li ; Mi, Qing Sheng ; Huang, Shuang ; She, Jin-Xiong ; Dong, Zheng. / MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival. In: Molecular Medicine. 2010 ; Vol. 16, No. 9-10. pp. 409-416.
@article{9a30b9b5111440dd87e6f3f241eb3045,
title = "MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival",
abstract = "MicroRNAs are small noncoding RNAs that are produced endogenously and have emerged as important regulators in pathophysiological conditions such as development and tumorigenesis. Very little is known about the regulation of microRNAs in renal diseases, including acute kidney injury (AKI). In this study, we examined the regulation of microRNA-34a (miR-34a) in experimental models of cisplatin-induced AKI and nephrotoxicity. By Northern blot and real-time polymerase chain reaction analyses, we detected an induction of miR-34a in vitro during cisplatin treatment of mouse proximal tubular cells and also in vivo during cisplatin nephrotoxicity in C57BL/6 mice. In cultured cells, miR-34a was induced within a few hours. In mice, miR-34a induction was detectable in renal tissues after 1 d of cisplatin treatment and increased to approximately four-fold of control at d 3. During cisplatin treatment, p53 was activated. Inhibition of p53 with pifithrin-α abrogated the induction of miR-34a during cisplatin treatment of proximal tubular cells. In vivo, miR-34a induction by cisplatin was abrogated in p53-deficient mice, a result that further confirms a role for p53 in miR-34a induction during cisplatin nephrotoxicity. Functionally, antagonism of miR-34a with specific antisense oligonucleotides increased cell death during cisplatin treatment. Collectively, the results suggest that miR-34a is induced via p53 during cisplatin nephrotoxicity and may play a cytoprotective role for cell survival.",
author = "Kirti Bhatt and Li Zhou and Mi, {Qing Sheng} and Shuang Huang and Jin-Xiong She and Zheng Dong",
year = "2010",
month = "9",
day = "1",
doi = "10.2119/molmed.2010.00002",
language = "English (US)",
volume = "16",
pages = "409--416",
journal = "Molecular Medicine",
issn = "1076-1551",
publisher = "Feinstein Institute for Medical Research",
number = "9-10",

}

TY - JOUR

T1 - MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival

AU - Bhatt, Kirti

AU - Zhou, Li

AU - Mi, Qing Sheng

AU - Huang, Shuang

AU - She, Jin-Xiong

AU - Dong, Zheng

PY - 2010/9/1

Y1 - 2010/9/1

N2 - MicroRNAs are small noncoding RNAs that are produced endogenously and have emerged as important regulators in pathophysiological conditions such as development and tumorigenesis. Very little is known about the regulation of microRNAs in renal diseases, including acute kidney injury (AKI). In this study, we examined the regulation of microRNA-34a (miR-34a) in experimental models of cisplatin-induced AKI and nephrotoxicity. By Northern blot and real-time polymerase chain reaction analyses, we detected an induction of miR-34a in vitro during cisplatin treatment of mouse proximal tubular cells and also in vivo during cisplatin nephrotoxicity in C57BL/6 mice. In cultured cells, miR-34a was induced within a few hours. In mice, miR-34a induction was detectable in renal tissues after 1 d of cisplatin treatment and increased to approximately four-fold of control at d 3. During cisplatin treatment, p53 was activated. Inhibition of p53 with pifithrin-α abrogated the induction of miR-34a during cisplatin treatment of proximal tubular cells. In vivo, miR-34a induction by cisplatin was abrogated in p53-deficient mice, a result that further confirms a role for p53 in miR-34a induction during cisplatin nephrotoxicity. Functionally, antagonism of miR-34a with specific antisense oligonucleotides increased cell death during cisplatin treatment. Collectively, the results suggest that miR-34a is induced via p53 during cisplatin nephrotoxicity and may play a cytoprotective role for cell survival.

AB - MicroRNAs are small noncoding RNAs that are produced endogenously and have emerged as important regulators in pathophysiological conditions such as development and tumorigenesis. Very little is known about the regulation of microRNAs in renal diseases, including acute kidney injury (AKI). In this study, we examined the regulation of microRNA-34a (miR-34a) in experimental models of cisplatin-induced AKI and nephrotoxicity. By Northern blot and real-time polymerase chain reaction analyses, we detected an induction of miR-34a in vitro during cisplatin treatment of mouse proximal tubular cells and also in vivo during cisplatin nephrotoxicity in C57BL/6 mice. In cultured cells, miR-34a was induced within a few hours. In mice, miR-34a induction was detectable in renal tissues after 1 d of cisplatin treatment and increased to approximately four-fold of control at d 3. During cisplatin treatment, p53 was activated. Inhibition of p53 with pifithrin-α abrogated the induction of miR-34a during cisplatin treatment of proximal tubular cells. In vivo, miR-34a induction by cisplatin was abrogated in p53-deficient mice, a result that further confirms a role for p53 in miR-34a induction during cisplatin nephrotoxicity. Functionally, antagonism of miR-34a with specific antisense oligonucleotides increased cell death during cisplatin treatment. Collectively, the results suggest that miR-34a is induced via p53 during cisplatin nephrotoxicity and may play a cytoprotective role for cell survival.

UR - http://www.scopus.com/inward/record.url?scp=77956642577&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956642577&partnerID=8YFLogxK

U2 - 10.2119/molmed.2010.00002

DO - 10.2119/molmed.2010.00002

M3 - Article

VL - 16

SP - 409

EP - 416

JO - Molecular Medicine

JF - Molecular Medicine

SN - 1076-1551

IS - 9-10

ER -